The non-canonical NF-κB pathway in immunity and inflammation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sun, S. C. & Ley, S. C. New insights into NF-κB regulation and function. Trends Immunol. 29, 469–478 (2008).
Lin, L., DeMartino, G. N. & Greene, W. C. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome. Cell 92, 819–828 (1998).
Vallabhapurapu, S. & Karin, M. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693–733 (2009).
Yang, H. T. et al. Coordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-κB1 p105. Mol. Cell. Biol. 32, 3438–3451 (2012).
Sriskantharajah, S. et al. Proteolysis of NF-κB1 p105 is essential for T cell antigen receptor-induced proliferation. Nat. Immunol. 10, 38–47 (2009).
Israel, A. The IKK complex, a central regulator of NF-κB activation. Cold Spring Harb. Perspect. Biol. 2, a000158 (2010).
Xiao, G., Harhaj, E. W. & Sun, S. C. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7, 401–409 (2001). This is the first paper to report inducible processing of p100 and to identify NIK as an inducing kinase.
Fong, A. & Sun, S.-C. Genetic evidence for the essential role of beta-transducin repeat-containing protein in the inducible processing of NF-κB2/p100. J. Biol. Chem. 277, 22111–22114 (2002).
Liang, C., Zhang, M. & Sun, S. C. β-TrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870. Cell. Signal. 18, 1309–1317 (2006).
Senftleben, U. et al. Activation of IKKa of a second, evolutionary conserved, NF-kB signaling pathway. Science 293, 1495–1499 (2001). This paper identifies IKK α as a NIK-target kinase that directly phosphorylates p100 to induce p100 processing.
Jin, W., Zhou, X. F., Yu, J., Cheng, X. & Sun, S. C. Regulation of Th17 cell differentiation and EAE induction by the MAP3K NIK. Blood 113, 6603–6610 (2009).
Boutaffala, L. et al. NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis. Cell Death Differ. 22, 2020–2033 (2015).
Hacker, H., Chi, L., Rehg, J. E. & Redecke, V. NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKalpha activation. J. Immunol. 188, 4602–4610 (2012).
Liu, B. et al. IKKalpha is required to maintain skin homeostasis and prevent skin cancer. Cancer Cell 14, 212–225 (2008).
Xiao, Z. et al. The pivotal role of IKKalpha in the development of spontaneous lung squamous cell carcinomas. Cancer Cell 23, 527–540 (2013).
Xiao, G., Fong, A. & Sun, S. C. Induction of p100 processing by NF-κB-inducing kinase involves docking IκB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J. Biol. Chem. 279, 30099–30105 (2004).
Sun, S.-C., Ganchi, P. A., Beraud, C., Ballard, D. W. & Greene, W. C. Autoregulation of the NF-kB transactivator Rel A (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl Acad. Sci. USA 91, 1346–1350 (1994).
Tucker, E. et al. A novel mutation in the Nfkb2 gene generates an NF-κ B2 “super repressor”. J. Immunol. 179, 7514–7522 (2007).
Zarnegar, B., Yamazaki, S., He, J. Q. & Cheng, G. Control of canonical NF-κB activation through the NIK-IKK complex pathway. Proc. Natl Acad. Sci. USA 105, 3503–3508 (2008).
Yu, J. et al. T cell-intrinsic function of the noncanonical NF-κB pathway in the regulation of GM-CSF expression and experimental autoimmune encephalomyelitis pathogenesis. J. Immunol. 193, 422–430 (2014).
De Silva, N. S., Silva, K., Anderson, M. M., Bhagat, G. & Klein, U. Impairment of mature B cell maintenance upon combined deletion of the alternative NF-κB transcription factors RELB and NF-κB2 in B cells. J. Immunol. 196, 2591–2601 (2016).
Shih, V. F. et al. Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways. Nat. Immunol. 13, 1162–1170 (2012).
Shinkura, R. et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κB-inducing kinase. Nat. Genet. 22, 74–77 (1999).
Dejardin, E. et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17, 525–535 (2002).
Claudio, E., Brown, K., Park, S., Wang, H. & Siebenlist, U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat. Immunol. 3, 958–965 (2002).
Coope, H. J. et al. CD40 regulates the processing of NF-κB2 p100 to p52. EMBO J. 15, 5375–5385 (2002).
Kayagaki, N. et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity 17, 515–524 (2002). References 29–32 are the first papers to report ligand-induced non-canonical NF-κB activation.
Saitoh, T. et al. TWEAK induces NF-κB2 p100 processing and long lasting NF-κB activation. J. Biol. Chem. 278, 36005–36012 (2003).
Ramakrishnan, P., Wang, W. & Wallach, D. Receptor-specific signaling for both the alternative and the canonical NF-κB activation pathways by NF-κB-inducing kinase. Immunity 21, 477–489 (2004).
Nishikori, M., Ohno, H., Haga, H. & Uchiyama, T. Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-κB p52, which is associated with hyperphosphorylated Bcl-3. Cancer Sci. 96, 487–497 (2005).
Nonaka, M. et al. Aberrant NF-κB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts. Oncogene 24, 3976–3986 (2005).
Novack, D. V. et al. The IκB function of NF-κB2 p100 controls stimulated osteoclastogenesis. J. Exp. Med. 198, 771–781 (2003).
Murray, S. E. et al. NF-κB-inducing kinase plays an essential T cell-intrinsic role in graft-versus-host disease and lethal autoimmunity in mice. J. Clin. Invest. 121, 4775–4786 (2011).
McPherson, A. J., Snell, L. M., Mak, T. W. & Watts, T. H. Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells. J. Biol. Chem. 287, 23010–23019 (2012).
Jin, J. et al. Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity. Immunity 40, 342–354 (2014).
Croft, M. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9, 271–285 (2009).
Xiao, X. et al. OX40 signaling favors the induction of TH9 cells and airway inflammation. Nat. Immunol. 13, 981–990 (2012).
Liu, P., Li, K., Garofalo, R. P. & Brasier, A. R. Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-κ B2 complexes via a novel retinoic acid-inducible gene-I·NF-κB-inducing kinase signaling pathway. J. Biol. Chem. 283, 23169–23178 (2008).
Manches, O., Fernandez, M. V., Plumas, J., Chaperot, L. & Bhardwaj, N. Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype. Proc. Natl Acad. Sci. USA 109, 14122–14127 (2012).
Ruckle, A. et al. The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cells. J. Virol. 86, 10211–10217 (2012).
Xiao, G. et al. Retroviral oncoprotein Tax induces processing of NF-κB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 20, 6805–6815 (2001).
Luftig, M. et al. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-κB activation. Proc. Natl Acad. Sci. USA 101, 141–146 (2004).
Matta, H. & Chaudhary, P. M. Activation of alternative NF-κ B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc. Natl Acad. Sci. USA 101, 9399–9404 (2004).
Cho, I. R. et al. Activation of non-canonical NF-κB pathway mediated by STP-A11, an oncoprotein of Herpesvirus saimiri. Virology 359, 37–45 (2007).
de Jong, S. J. et al. Noncanonical NF-κB activation by the oncoprotein Tio occurs through a nonconserved TRAF3-binding motif. Sci. Signal. 6, ra27 (2013).
Ohmae, T. et al. Helicobacter pylori activates NF-κB via the alternative pathway in B lymphocytes. J. Immunol. 175, 7162–7169 (2005).
Ge, J. et al. A Legionella type IV effector activates the NF-κB pathway by phosphorylating the IκB family of inhibitors. Proc. Natl Acad. Sci. USA 106, 13725–13730 (2009).
Liao, G., Zhang, M., Harhaj, E. W. & Sun, S. C. Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279, 26243–26250 (2004). This paper demonstrates that NIK is regulated by TRAF3-dependent proteolysis and activated via signal-induced TRAF3 degradation.
He, J. Q. et al. Rescue of TRAF3-null mice by p100 NF-κ B deficiency. J. Exp. Med. 203, 2413–2418 (2006).
Sasaki, Y. et al. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells. Proc. Natl Acad. Sci. USA 105, 10883–10888 (2008).
de Leon-Boenig, G. et al. The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site. Structure 20, 1704–1714 (2012).
Liu, J. et al. Structure of the nuclear factor κB-inducing kinase (NIK) kinase domain reveals a constitutively active conformation. J. Biol. Chem. 287, 27326–27334 (2012).
Vallabhapurapu, S. et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nat. Immunol. 9, 1364–1370 (2008).
Zarnegar, B. J. et al. Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371–1378 (2008). References 58 and 59 propose a model whereby TRAF3 functions as a cIAP–TRAF2–TRAF3 complex to mediate NIK ubiquitylation.
Gardam, S., Sierro, F., Basten, A., Mackay, F. & Brink, R. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28, 391–401 (2008).
Grech, A. P. et al. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells. Immunity 21, 629–642 (2004).
Xie, P., Stunz, L. L., Larison, K. D., Yang, B. & Bishop, G. A. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 27, 253–267 (2007).
Gardam, S. et al. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood 117, 4041–4051 (2011).
Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFalpha-dependent apoptosis. Cell 131, 669–681 (2007).
Vince, J. E. et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131, 682–693 (2007). References 64 and 65 demonstrated the involvement of cIAP in the negative regulation of non-canonical NF-κB pathway.
Allen, I. C. et al. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity 36, 742–754 (2012).
Lich, J. D. et al. Monarch-1 suppresses non-canonical NF-κB activation and p52-dependent chemokine expression in monocytes. J. Immunol. 178, 1256–1260 (2007).
Hu, H. et al. OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3. Nature 494, 371–374 (2013). This study identified the OTUD7B as a deubiquitinase of TRAF3 that controls non-canonical NF-κB signalling.
Razani, B. et al. Negative feedback in non-canonical NF-κB signaling modulates NIK stability through IKKα-mediated phosphorylation. Sci. Signal. 3, ra41 (2010).
Jin, J. et al. The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling. Nat. Immunol. 13, 1101–1109 (2012).
Maminska, A. et al. ESCRT proteins restrict constitutive NF-κB signaling by trafficking cytokine receptors. Sci. Signal. 9, ra8 (2016).
Morrison, M. D., Reiley, W., Zhang, M. & Sun, S. C. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-κB signaling pathway. J. Biol. Chem. 280, 10018–10024 (2005).
Sanjo, H., Zajonc, D. M., Braden, R., Norris, P. S. & Ware, C. F. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor. J. Biol. Chem. 285, 17148–17155 (2010).
Ganeff, C. et al. Induction of the alternative NF-κB pathway by lymphotoxin alphabeta (LTalphabeta) relies on internalization of LTbeta receptor. Mol. Cell. Biol. 31, 4319–4334 (2011).
Jane-wit, D. et al. Complement membrane attack complexes activate noncanonical NF-κB by forming an Akt+ NIK+ signalosome on Rab5+ endosomes. Proc. Natl Acad. Sci. USA 112, 9686–9691 (2015).
Dejardin, E. The alternative NF-κB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol. 72, 1161–1179 (2006).
Weih, F. & Caamaño, J. Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway. Immunol. Rev. 195, 91–105 (2003).
Miyawaki, S. et al. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24, 429–434 (1994).
Matsushima, A. et al. Essential role of nuclear factor (NF)-κB-inducing kinase and inhibitor of κB (IκB) kinase alpha in NF-κB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I. J. Exp. Med. 193, 631–636 (2001).
Yilmaz, Z. B., Weih, D. S., Sivakumar, V. & Weih, F. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 22, 121–130 (2003).
Carragher, D. et al. A stroma-derived defect in NF-κB2−/− mice causes impaired lymph node development and lymphocyte recruitment. J. Immunol. 173, 2271–2279 (2004).
Lo, J. C. et al. Coordination between NF-κB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues. Blood 107, 1048–1055 (2006).
van de Pavert, S. A. & Mebius, R. E. New insights into the development of lymphoid tissues. Nat. Rev. Immunol. 10, 664–674 (2010).
Akiyama, T. et al. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29, 423–437 (2008).
Burkly, L. et al. Expression of relB is required for the development of thymic medulla and dentritic cells. Nature 373, 531–536 (1995).
Weih, F. et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κ B/Rel family. Cell 80, 331–340 (1995).
Kajiura, F. et al. NF-κ B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J. Immunol. 172, 2067–2075 (2004).
Kinoshita, D. et al. Essential role of IκB kinase alpha in thymic organogenesis required for the establishment of self-tolerance. J. Immunol. 176, 3995–4002 (2006).
Akiyama, T. et al. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science 308, 248–251 (2005).
Onder, L. et al. Alternative NF-κB signaling regulates mTEC differentiation from podoplanin-expressing presursors in the cortico-medullary junction. Eur. J. Immunol. 45, 2218–2231 (2015).
Baik, S., Sekai, M., Hamazaki, Y., Jenkinson, W. E. & Anderson, G. Relb acts downstream of medullary thymic epithelial stem cells and is essential for the emergence of RANK+ medullary epithelial progenitors. Eur. J. Immunol. 46, 857–862 (2016).
Zhu, M. et al. NF-κB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J. Clin. Invest. 116, 2964–2971 (2006).
LaFlam, T. N. et al. Identification of a novel cis-regulatory element essential for immune tolerance. J. Exp. Med. 212, 1993–2002 (2015).
Haljasorg, U. et al. A highly conserved NF-κB-responsive enhancer is critical for thymic expression of Aire in mice. Eur. J. Immunol. 45, 3246–3256 (2015).
Steinman, R. M. & Hemmi, H. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311, 17–58 (2006).
Summers deLuca, L. & Gommerman, J. L. Fine-tuning of dendritic cell biology by the TNF superfamily. Nat. Rev. Immunol. 12, 339–351 (2012).
Gerondakis, S. et al. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models. Oncogene 25, 6781–6799 (2006).
Seki, T. et al. Visualization of RelB expression and activation at the single-cell level during dendritic cell maturation in Relb-Venus knock-in mice. J. Biochem. 158, 485–495 (2015).
Lind, E. F. et al. Dendritic cells require the NF-κB2 pathway for cross-presentation of soluble antigens. J. Immunol. 181, 354–363 (2008).
Katakam, A. K. et al. Dendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cells. Proc. Natl Acad. Sci. USA 112, 14664–14669 (2015).
Hammer, G. E. & Ma, A. Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu. Rev. Immunol. 31, 743–791 (2013).
Tas, S. W. et al. Noncanonical NF-κB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 110, 1540–1549 (2007).
Kim, N. S. et al. Chimeric vaccine stimulation of human dendritic cell indoleamine 2, 3-dioxygenase occurs via the non-canonical NF-κB pathway. PLoS ONE 11, e0147509 (2016).
Choudhary, S., Boldogh, S., Garofalo, R., Jamaluddin, M. & Brasier, A. R. Respiratory syncytial virus influences NF-κB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-κB2. J. Virol. 79, 8948–8959 (2005).
Willmann, K. L. et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat. Commun. 5, 5360 (2014).
Chen, K. et al. Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. Am. J. Hum. Genet. 93, 812–824 (2013).
Lee, C. E. et al. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. Blood 124, 2964–2972 (2014).
Lindsley, A. W. et al. Combined immune deficiency in a patient with a novel NFKB2 mutation. J. Clin. Immunol. 34, 910–915 (2014).
Mesin, L., Ersching, J. & Victora, G. D. Germinal center B cell dynamics. Immunity 45, 471–482 (2016).
Caamano, J. H. et al. Nuclear factor (NF)-κ B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187, 185–196 (1998).
Franzoso, G. et al. Mice deficient in nuclear factor (NF)-κ B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187, 147–159 (1998).
Weih, D. S., Yilmaz, Z. B. & Weih, F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167, 1909–1919 (2001).
Mills, D. M., Bonizzi, G., Karin, M. & Rickert, R. C. Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals. Proc. Natl Acad. Sci. USA 104, 6359–6364 (2007).
Yamada, T. et al. Abnormal Immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase. J. Immunol. 165, 804–812 (2000).
Brightbill, H. D. et al. Conditional deletion of NF-κB-inducing kinase (NIK) in adult mice disrupts mature B cell survival and activation. J. Immunol. 195, 953–964 (2015).
Hahn, M., Macht, A., Waisman, A. & Hovelmeyer, N. NF-κB-inducing kinase is essential for B-cell maintenance in mice. Eur. J. Immunol. 46, 732–741 (2016).
De Silva, N. S. et al. Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development. Proc. Natl Acad. Sci. USA 113, 9063–9068 (2016).
Linterman, M. A. & Vinuesa, C. G. Signals that influence T follicular helper cell differentiation and function. Semin. Immunopathol. 32, 183–196 (2010).
Hu, H. et al. Noncanonical NF-κB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development. Proc. Natl Acad. Sci. USA 108, 12827–12832 (2011).
Brue, T. et al. Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies. BMC Med. Genet. 15, 139 (2014).
Shin, C. et al. CD8alpha− dendritic cells induce antigen-specific T follicular helper cells generating efficient humoral immune responses. Cell Rep. 11, 1929–1940 (2015).
O'Shea, J. J. & Paul, W. E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098–1102 (2010).
Li, Y. et al. Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses. Sci. Rep. 6, 22115 (2016).
Rowe, A. M. et al. A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory. J. Immunol. 191, 3663–3672 (2013).
Tamura, C. et al. Impaired function of dendritic cells in alymphoplasia (aly/aly) mice for expansion of CD25+CD4+ regulatory T cells. Autoimmunity 39, 445–453 (2006).
Murray, S. E. Cell-intrinsic role for NF-κ B-inducing kinase in peripheral maintenance but not thymic development of Foxp3+ regulatory T cells in mice. PLoS ONE 8, e76216 (2013).
Elewaut, D. et al. NIK-dependent RelB activation defines a unique signaling pathway for the development of Vα14i NKT Cells. J. Exp. Med. 16, 1623–1633 (2003).
Sivakumar, V., Hammond, K. J., Howells, N., Pfeffer, K. & Weih, F. Differential requirement for Rel/nuclear factor κB family members in natural killer T cell development. J. Exp. Med. 197, 1613–1621 (2003).
Mair, F. et al. The NFκB-inducing kinase is essential for the developmental programming of skin-resident and IL-17-producing gammadelta T cells. eLife 4, e10087 (2015).
Ashley, N. T., Weil, Z. M. & Nelson, R. J. Inflammation: mechanisms, costs, and natural variation. Annu. Rev. Ecol. Evol. Syst. 43, 385–406 (2012).
McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205–2219 (2011).
Noort, A. R., Tak, P. P. & Tas, S. W. Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? Arthritis Res. Ther. 17, 15 (2015).
Vinay, D. S. & Kwon, B. S. Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis. Cytokine 57, 305–312 (2012).
Noort, A. R. et al. NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis. J. Pathol. 234, 375–385 (2014).
Maijer, K. I. et al. Nuclear factor-κB-inducing kinase is expressed in synovial endothelial cells in patients with early arthritis and correlates with markers of inflammation: a prospective cohort study. J. Rheumatol 42, 1573–1581 (2015).
Noort, A. R. et al. Tertiary lymphoid structures in rheumatoid arthritis: NF-κB-inducing kinase-positive endothelial cells as central players. Am. J. Pathol. 185, 1935–1943 (2015).
Baum, R. & Gravallese, E. M. Bone as a target organ in rheumatic disease: impact on osteoclasts and osteoblasts. Clin. Rev. Allergy Immunol. 51, 1–15 (2016).
Aya, K. et al. NF-κB-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis. J. Clin. Invest. 115, 1848–1854 (2005).
Yao, Z., Xing, L. & Boyce, B. F. NF-κB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. J. Clin. Invest. 119, 3024–3034 (2009).
Xiu, Y. et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J. Clin. Invest. 124, 297–310 (2014).
Yang, C. et al. NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis. PLoS ONE 5, e15383 (2010).
Wei, F., Chang, Y. & Wei, W. The role of BAFF in the progression of rheumatoid arthritis. Cytokine 76, 537–544 (2015).
Mackay, F. & Tangye, S. G. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr. Opin. Pharmacol. 4, 347–354 (2004).
Sanz, I. & Lee, F. E. B cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 6, 326–337 (2010).
Zhang, J. et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166, 6–10 (2001).
Petri, M. et al. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum. 58, 2453–2459 (2008).
Stohl, W. Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE). Expert Rev. Clin. Immunol. http://dx.doi.org/10.1080/1744666X.2017.1291343 (2017).
McCarthy, D. D. et al. Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J. Clin. Invest. 121, 3991–4002 (2011).
Poveda, J. et al. TWEAK/Fn14 and non-canonical NF-κB signaling in kidney disease. Front. Immunol. 4, 447 (2013).
Sakai, N. et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc. Natl Acad. Sci. USA 103, 14098–14103 (2006).
Sanz, A. B. et al. TWEAK activates the non-canonical NFκB pathway in murine renal tubular cells: modulation of CCL21. PLoS ONE 5, e8955 (2010).
Valino-Rivas, L. et al. Non-canonical NFκB activation promotes chemokine expression in podocytes. Sci. Rep. 6, 28857 (2016).
Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98–107 (2011).
Choudhary, S. et al. NF-κB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: blockade by adiponectin. Endocrinology 152, 3622–3627 (2011).
Sheng, L. et al. NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat. Med. 18, 943–949 (2012). This is a key report demonstrating the involvement of NIK in metabolic diseases.
Starkey, J. M. et al. Diabetes-induced activation of canonical and noncanonical nuclear factor-κB pathways in renal cortex. Diabetes 55, 1252–1259 (2006).
Malle, E. K. et al. Nuclear factor κB-inducing kinase activation as a mechanism of pancreatic beta cell failure in obesity. J. Exp. Med. 212, 1239–1254 (2015).
Kiechl, S. et al. Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat. Med. 19, 358–363 (2013).
Kim, W. H. et al. Additive activation of hepatic NF-κB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms. FASEB J. 15, 2551–2553 (2001).
Shen, H. et al. Mouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis. Hepatology 60, 2065–2076 (2014).
Ren, X. et al. A small-molecule inhibitor of NF-κB-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury. FASEB J. 31, 711–718 (2017).
Simmons, S. B., Pierson, E. R., Lee, S. Y. & Goverman, J. M. Modeling the heterogeneity of multiple sclerosis in animals. Trends Immunol. 34, 410–422 (2013).
Hofmann, J., Mair, F., Greter, M., Schmidt-Supprian, M. & Becher, B. NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses. J. Exp. Med. 208, 1917–1929 (2011).
Hussman, J. P. et al. GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis. Genes Immun. 17, 305–312 (2016).
Etemadi, N. et al. TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of sphingosine kinase 1. eLife 4, e10592 (2015).
Cai, Y. et al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35, 596–610 (2011).
Eshima, K. et al. Significant involvement of nuclear factor-κB-inducing kinase in proper differentiation of alphabeta and gammadelta T cells. Immunology 141, 222–232 (2014).
Burkitt, M. D. et al. NF-κB1, NF-κB2 and c-Rel differentially regulate susceptibility to colitis-associated adenoma development in C57BL/6 mice. J. Pathol. 236, 326–336 (2015).
Banoth, B. et al. Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection. eLife 4, e05648 (2015).
Wang, Y. et al. Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 32, 403–413 (2010).